CM Ballantyne

First name:
CM
Last name:
Ballantyne
Vazir, A., Claggett, B., Cheng, S., Skali, H., Shah, A., Agulair, D., et al. (2018). Association of Resting Heart Rate and Temporal Changes in Heart Rate With Outcomes in Participants of the Atherosclerosis Risk in Communities Study. Jama Cardiology. https://doi.org/10.1001/jamacardio.2017.4974 (Original work published 2018)
View
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., et al. (2019). Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. The New England Journal Of Medicine, 380(1), 11-22. https://doi.org/10.1056/NEJMoa1812792 (Original work published 2019)
View
Verma, S., Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., et al. (2021). Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG. Circulation, 144(23), 1845-1855. https://doi.org/10.1161/CIRCULATIONAHA.121.056290 (Original work published 2021)
View